Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society-Reference-Cited by-同舟云学术

Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society

Published:2023-08-09 Issue:6 Volume:17 Page:1711-1721
ISSN:1932-2968
Container-title:Journal of Diabetes Science and Technology
language:en
Short-container-title:J Diabetes Sci Technol

Author:

Tian Tiffany¹^ORCID,Aaron Rachel E.¹^ORCID,Huang Jingtong¹^ORCID,Yeung Andrea M.¹^ORCID,Svensson Jannet²³^ORCID,Gentile Sandro⁴⁵^ORCID,Forbes Angus⁶^ORCID,Heinemann Lutz⁷^ORCID,Seley Jane Jeffrie⁸^ORCID,Kerr David¹^ORCID,Klonoff David C.⁹^ORCID

Affiliation:

1. Diabetes Technology Society, Burlingame, CA, USA

2. Steno Diabetes Center Copenhagen, Herlev, Denmark

3. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

4. Department of Internal Medicine, Campania University “Luigi Vanvitelli,” Naples, Italy

5. Diabetes Unit AID Stabia, Nefrocenter Research and Nyx Start-Up, Naples, Italy

6. Division of Care in Long-term Conditions, King’s College London, London, UK

7. Science Consulting in Diabetes, Kaarst, Germany

8. Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine, New York, NY, USA

9. Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA

Abstract

Lipohypertrophy is a common skin complication associated with insulin-treated diabetes. The impact of lipohypertrophy as a contributing factor to suboptimal glycemic control, glucose variability, and hypoglycemia is often under-recognized by health care professionals. In a recent Webinar on April 26, 2023, Diabetes Technology Society asked international experts to provide updates on the latest knowledge related to lipohypertrophy for practicing clinicians and educators, researchers, and industries involved in insulin delivery. A recording of the Webinar is freely available on the Diabetes Technology Society Web site ( https://www.diabetestechnology.org/ ).

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/19322968231187661

Reference47 articles.

1. Reeves WG, Allen BR, Tattersall RB. Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Br Med J. 1980;280(6230):1500-1503. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1601688/. Accessed June 20, 2023.